DK1339411T3 - Anvendelse af zoledronsyre til smertebehandling - Google Patents

Anvendelse af zoledronsyre til smertebehandling

Info

Publication number
DK1339411T3
DK1339411T3 DK01998352T DK01998352T DK1339411T3 DK 1339411 T3 DK1339411 T3 DK 1339411T3 DK 01998352 T DK01998352 T DK 01998352T DK 01998352 T DK01998352 T DK 01998352T DK 1339411 T3 DK1339411 T3 DK 1339411T3
Authority
DK
Denmark
Prior art keywords
patient
zoledronic acid
pain management
treatment
pain
Prior art date
Application number
DK01998352T
Other languages
Danish (da)
English (en)
Inventor
Alyson Fox
Jonathan Green
Terence O'reilly
Laszlo Urban
Katharine Walker
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1339411T3 publication Critical patent/DK1339411T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK01998352T 2000-11-29 2001-11-27 Anvendelse af zoledronsyre til smertebehandling DK1339411T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029111.2A GB0029111D0 (en) 2000-11-29 2000-11-29 Organic compounds
PCT/EP2001/013836 WO2002043738A2 (en) 2000-11-29 2001-11-27 Use of bisphosphonates for pain treatment

Publications (1)

Publication Number Publication Date
DK1339411T3 true DK1339411T3 (da) 2007-10-29

Family

ID=9904112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01998352T DK1339411T3 (da) 2000-11-29 2001-11-27 Anvendelse af zoledronsyre til smertebehandling

Country Status (27)

Country Link
US (2) US20040063670A1 (cs)
EP (1) EP1339411B1 (cs)
JP (1) JP2004514696A (cs)
KR (2) KR100866025B1 (cs)
CN (1) CN1535152A (cs)
AT (1) ATE366112T1 (cs)
AU (2) AU1706102A (cs)
BR (1) BR0115696A (cs)
CA (1) CA2427161C (cs)
CY (1) CY1106851T1 (cs)
CZ (1) CZ301701B6 (cs)
DE (1) DE60129242T2 (cs)
DK (1) DK1339411T3 (cs)
ES (1) ES2287191T3 (cs)
GB (1) GB0029111D0 (cs)
HU (1) HUP0302556A3 (cs)
IL (2) IL155363A0 (cs)
MX (1) MXPA03004815A (cs)
NO (1) NO20032405L (cs)
NZ (1) NZ525871A (cs)
PL (1) PL204001B1 (cs)
PT (1) PT1339411E (cs)
RU (1) RU2325913C2 (cs)
SK (1) SK287501B6 (cs)
TW (1) TWI275393B (cs)
WO (1) WO2002043738A2 (cs)
ZA (1) ZA200303247B (cs)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
WO2002062351A1 (en) 2001-02-06 2002-08-15 The Royal Alexandra Hospital For Children A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
US7875597B2 (en) * 2002-07-24 2011-01-25 New York University Treatment of spinal mechanical pain
CA2554749A1 (en) * 2004-01-30 2005-08-11 Astellas Pharma Inc. P2x receptor inhibitor
EP1755598A4 (en) * 2004-05-06 2008-04-30 Merck & Co Inc METHOD FOR THE TREATMENT OF ARTHRITICAL ILLNESSES IN DOGS
DE602005025977D1 (de) * 2004-08-23 2011-03-03 Teva Pharma Kristalline form des ibandronat-natriums und herstellungsverfahren dafür
CA2622322A1 (en) 2005-09-16 2007-03-22 Selamine Ltd Bisphosphonate formulation
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
EP2526950A1 (en) 2006-04-07 2012-11-28 Merrion Research III Limited Solid oral dosage form containing an enhancer
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
US8974801B2 (en) 2006-12-21 2015-03-10 Amphastar Pharmaceuticals Inc. Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
ITPA20070034A1 (it) * 2007-10-30 2009-04-30 Tetrapharm S R L Bifosfonati geminali, loro preparazione e loro impiego in campo oncologico.
KR20100092035A (ko) * 2007-11-30 2010-08-19 노파르티스 아게 Ｃ2-ｃ5-알킬-이미다졸-비스포스포네이트
EP2273980A2 (en) * 2008-04-04 2011-01-19 Novartis AG Pharmaceutical composition with bisphosphonate
AU2009244797B2 (en) 2008-05-07 2015-01-22 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
MX2011006605A (es) * 2008-12-23 2011-06-30 Novartis Ag Compuestos de fenilalquilo-imidazol-bifosfonato.
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
GB201011552D0 (en) * 2010-07-09 2010-08-25 Smith & Nephew Adhesive and a method of delivery
HRP20150666T1 (hr) 2010-09-02 2015-07-31 Naturland Magyarország Termelö És Kereskedelmi Kft. Pripravak za peroralnu primjenu s histaminazom biljnog podrijetla, rezistentnom na pepsin i tripsin i postupak proizvodnje istog
ITNA20100046A1 (it) * 2010-09-28 2012-03-29 Abbruzzese Saccardi Alberto Uso di bisfosfonati per la preparazione di formulazioni farmaceutiche per il trattamento dei sintomi associati a dolore neuropatico
WO2012094598A2 (en) 2011-01-07 2012-07-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP6268100B2 (ja) * 2011-12-11 2018-01-24 レクロ・ファーマ，インコーポレーテッド 鼻腔内デクスメデトミジン組成物およびその使用方法
US20170065625A1 (en) * 2012-05-14 2017-03-09 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US10413561B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US10028908B2 (en) 2012-05-14 2018-07-24 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9867839B2 (en) 2012-05-14 2018-01-16 Antecip Bioventures Ii Llc Osteoclast inhibitors for joint conditions
US8865757B1 (en) 2014-05-28 2014-10-21 Antecip Bioventures Ii Llp Therapeutic compositions comprising imidazole and imidazolium compounds
US9795622B2 (en) 2012-05-14 2017-10-24 Antecip Bioventures Ii Llc Neridronic acid for treating pain associated with a joint
US9827256B2 (en) 2014-05-27 2017-11-28 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating lower back pain
US10493085B2 (en) 2012-05-14 2019-12-03 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US9707245B2 (en) 2012-05-14 2017-07-18 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US9999629B2 (en) 2012-05-14 2018-06-19 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9694023B2 (en) 2012-05-14 2017-07-04 Antecip Bioventures Ii Llc Methods for the safe administration of imidazole or imidazolium compounds
US9956238B2 (en) 2014-05-15 2018-05-01 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US10004756B2 (en) 2014-05-15 2018-06-26 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9901589B2 (en) * 2012-05-14 2018-02-27 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10034890B2 (en) 2012-05-14 2018-07-31 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9707247B2 (en) 2012-05-14 2017-07-18 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9770457B2 (en) 2012-05-14 2017-09-26 Antecip Bioventures Ii Llc Neridronic acid for treating bone marrow lesion
US9925203B2 (en) 2012-05-14 2018-03-27 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9662343B2 (en) 2012-05-14 2017-05-30 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
PT2849758T (pt) * 2012-05-14 2018-05-09 Antecip Bioventures Ii Llc Composições que compreendem o ácido zoledrónico ou compostos relacionados para o alívio da dor inflamatória e estados relacionados
US9789128B2 (en) 2012-05-14 2017-10-17 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US20170128472A1 (en) * 2012-05-14 2017-05-11 Antecip Bioventures Ii Llc Administration of Zoledronic Acid to Treat Pain Associated with Ankylosing Spondylitis
US9867840B2 (en) 2014-05-27 2018-01-16 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9616078B2 (en) 2012-05-14 2017-04-11 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US9956237B2 (en) 2012-05-14 2018-05-01 Antecip Bioventures Ii Llc Osteoclast inhibitors for knee conditions
US9820999B2 (en) 2012-05-14 2017-11-21 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US10413560B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US10463682B2 (en) 2012-05-14 2019-11-05 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
US9675626B2 (en) 2012-05-14 2017-06-13 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9211257B2 (en) * 2012-05-14 2015-12-15 Antecip Bioventures Ii Llc Osteoclast inhibitors for knee conditions
US10350227B2 (en) 2012-05-14 2019-07-16 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US10111837B2 (en) 2012-05-14 2018-10-30 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds
US9999628B2 (en) 2012-05-14 2018-06-19 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US10173986B2 (en) 2012-05-14 2019-01-08 Antecip Bioventures Ii Llc Methods for the safe administration of imidazole or imidazolium compounds
US11654152B2 (en) * 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
US9949993B2 (en) 2012-05-14 2018-04-24 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US10092581B2 (en) 2014-05-15 2018-10-09 Antecip Bioventures Ii Llc Osteoclast inhibitors such as zoledronic acid for low back pain treatment
US10016446B2 (en) 2012-05-14 2018-07-10 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone
US9717747B2 (en) 2012-05-14 2017-08-01 Antecip Bioventures Ii Llc Osteoclast inhibitors for knee conditions
US9782421B1 (en) 2012-05-14 2017-10-10 Antecip Bioventures Ii Llc Neridronic acid molecular complex for treating complex regional pain syndrome
US9427403B2 (en) 2012-05-14 2016-08-30 Antecip Bioventures Ii Llc Methods for the safe administration of imidazole or imidazolium compounds
US9655908B2 (en) 2012-05-14 2017-05-23 Antecip Bioventures Ii Llc Neridronic acid molecular complex for treating complex regional pain syndrome
US9700570B2 (en) 2014-05-27 2017-07-11 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9827192B2 (en) 2012-05-14 2017-11-28 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9861648B2 (en) 2012-05-14 2018-01-09 Antecip Boiventures Ii Llc Osteoclast inhibitors for knee conditions
US8802658B2 (en) 2012-05-14 2014-08-12 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
US9877977B2 (en) 2012-05-14 2018-01-30 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US20170056427A1 (en) * 2012-05-14 2017-03-02 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US9669040B2 (en) 2012-05-14 2017-06-06 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9844559B2 (en) 2012-05-14 2017-12-19 Antecip Bioventures Ii Llc Neridronic acid for treating bone marrow lesions
US20170095488A1 (en) * 2012-05-14 2017-04-06 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10028969B2 (en) 2012-05-14 2018-07-24 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9943531B2 (en) 2014-08-08 2018-04-17 Antecip Bioventures Ii Llc Osteoclast inhibitors such as zoledronic acid for low back pain treatment
US9956234B2 (en) 2012-05-14 2018-05-01 Antecip Bioventures Ii Llc Osteoclast inhibitors for joint conditions
US9895383B2 (en) * 2012-05-14 2018-02-20 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10080765B2 (en) 2012-05-14 2018-09-25 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US10016445B2 (en) 2012-05-14 2018-07-10 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US20170071960A1 (en) * 2012-05-14 2017-03-16 Antecip Bioventures Ii Llc Osteoclast inhibitors for knee conditions
US9289441B2 (en) 2014-08-08 2016-03-22 Antecip Bioventures Ii Llc Osteoclast inhibitors such as zoledronic acid for low back pain treatment
US20150051175A1 (en) * 2012-05-14 2015-02-19 Antecip Bioventures Ii Llc Co-Administration of Steroids and Zoledronic Acid to Prevent and Treat Pain
US10039773B2 (en) 2012-05-14 2018-08-07 Antecip Bioventures Ii Llc Neridronic acid for treating arthritis
CN102961785A (zh) * 2012-11-09 2013-03-13 于秀淳 一种用于治疗骨巨细胞瘤的瘤腔填充物及其制备方法
US8859530B2 (en) 2013-03-08 2014-10-14 Voltarra Pharmaceuticals, Inc. Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
US9012432B2 (en) * 2013-03-08 2015-04-21 Levolta Pharmaceuticals, Inc. Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
CN108434154A (zh) * 2013-10-25 2018-08-24 安泰赛普生物风投二代有限责任公司 用于治疗疾病的唑来膦酸或相关化合物的经口施用组合物
US9127069B1 (en) 2014-06-11 2015-09-08 Antecip Bioventures LLC Compositions comprising rank/rankl antagonists and related compounds for treating pain
US9079927B1 (en) 2014-05-27 2015-07-14 Antecip Bioventures Ii Llc Substituted imidazolium compounds for treating disease
US9688765B2 (en) 2014-06-11 2017-06-27 Antecip Bioventures Ii Llc Methods using RANK/RANKL antagonist antibodies for treating pain
ES2975708T3 (es) 2015-01-29 2024-07-12 Novo Nordisk As Comprimidos que comprenden agonista del GLP-1 y recubrimiento entérico
CN107011380A (zh) * 2016-01-28 2017-08-04 臧伟 一种二膦酸衍生物及含二膦酸衍生物的组合物治疗骨折的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FI92465C (fi) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US6008206A (en) * 1994-09-21 1999-12-28 Merck & Co., Inc. Sodium alendronate preparation for local administration
JP3411690B2 (ja) * 1994-09-21 2003-06-03 帝人株式会社 局所投与用アレンドロン酸ナトリウム製剤
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
US5914099A (en) * 1995-05-12 1999-06-22 Merck & Co., Inc. Prevention of tooth loss by the administration of alendronate or its salts
US5988390A (en) * 1997-06-26 1999-11-23 Reese Products, Inc. Trailer shipping container
DE19731205A1 (de) * 1997-07-21 1999-01-28 Siemens Ag Verfahren und Funk-Kommunikationssystem zur Informationsübertragung mittels ATM-Zellen
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
EP1128813B1 (en) * 1998-11-12 2007-02-14 Inc. Transave An inhalation system
US6331533B1 (en) * 1998-11-16 2001-12-18 Merck & Co., Inc. Method for inhibiting dental resorptive lesions
AU1525700A (en) * 1998-11-19 2000-06-05 Board Of Trustees Of The University Of Arkansas, The Increasing bone strength with selected bisphosphonates
RU2153358C1 (ru) * 1999-11-10 2000-07-27 Центральный научно-исследовательский рентгенорадиологический институт МЗ России Способ лечения остеолитических метастазов
DE10049404C2 (de) * 2000-10-05 2003-01-30 Fraunhofer Ges Forschung Mit einem NIR-Marker versehener kunststoff-, glas-, textil- oder papierhaltiger Werkstoff und Verfahren zur Identifizierung dieses Werkstoffs

Also Published As

Publication number Publication date
RU2003117702A (ru) 2005-02-27
MXPA03004815A (es) 2003-09-25
DE60129242T2 (de) 2008-03-13
GB0029111D0 (en) 2001-01-10
NO20032405D0 (no) 2003-05-27
HUP0302556A3 (en) 2005-02-28
TWI275393B (en) 2007-03-11
CA2427161C (en) 2013-03-05
ATE366112T1 (de) 2007-07-15
AU1706102A (en) 2002-06-11
PL204001B1 (pl) 2009-12-31
EP1339411A2 (en) 2003-09-03
SK287501B6 (sk) 2010-12-07
BR0115696A (pt) 2004-02-10
KR20080043409A (ko) 2008-05-16
KR100866025B1 (ko) 2008-10-30
NO20032405L (no) 2003-05-27
SK6542003A3 (en) 2003-12-02
CZ20031467A3 (cs) 2003-09-17
WO2002043738A3 (en) 2003-03-27
US20040063670A1 (en) 2004-04-01
JP2004514696A (ja) 2004-05-20
WO2002043738A2 (en) 2002-06-06
IL155363A (en) 2008-04-13
IL155363A0 (en) 2003-11-23
HUP0302556A2 (hu) 2003-11-28
PT1339411E (pt) 2007-10-12
AU2002217061B2 (en) 2005-04-28
CN1535152A (zh) 2004-10-06
CA2427161A1 (en) 2002-06-06
DE60129242D1 (de) 2007-08-16
ZA200303247B (en) 2004-05-10
ES2287191T3 (es) 2007-12-16
EP1339411B1 (en) 2007-07-04
CZ301701B6 (cs) 2010-05-26
PL361774A1 (en) 2004-10-04
KR20030057544A (ko) 2003-07-04
US20080207565A1 (en) 2008-08-28
RU2325913C2 (ru) 2008-06-10
CY1106851T1 (el) 2012-05-23
NZ525871A (en) 2005-04-29

Similar Documents

Publication Publication Date Title
DK1339411T3 (da) Anvendelse af zoledronsyre til smertebehandling
CY1106457T1 (el) Φαρμακευτικη συνθεση για τη χρηση σε θepαπεια ορμονικης υποκαταστασεως
DK1178810T3 (da) Anvendelse af bisphosphonsyrer til behandling af angiogenese
ATE529125T1 (de) Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung
DK1587506T3 (da) Administration af capsaicinoider
HRP20040352B1 (en) Use of flibanserin in the treatment of sexual disorders
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
HRP20041013B1 (hr) Formulacija visoke doze ibandronata
SE0400184D0 (sv) New therapeutical use
TW200640467A (en) Compounds and uses thereof
WO2001089494A3 (en) Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
BRPI0408500A (pt) tratamento do diabetes do tipo 1 com inibidores de pde5
DK1443942T3 (da) Farmaceutisk sammensætning til anvendelse ved behandling af maligniteter omfattende en kombination af et bisphosphonat, en COX-2 inhibitor og en taxol
TW200600084A (en) Anti-coronavirus compounds
HK1080370A1 (zh) 用於治疗动脉硬化症的二磷酸酯及包含它们的装置
ES2152865A1 (es) Utilizacion de bisfosfonatos en la preparacion de composiciones farmaceuticas para uso intramuscular.
DK1536777T3 (da) Anvendelse af NF-KB-inhibitorer til behandling af mastitis
CY1114408T1 (el) Ελεγχομενης αποσυνθεσης συνθεση που περιεχει ενα αλας στροντιου
TH51552A (th) การใช้กรดบิสฟอสโฟนิคสำหรับการบำบัดแอนจิโอจีนีซิส